WallStreetZenWallStreetZen

NASDAQ: FLGC
Flora Growth Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for FLGC

Based on 2 analysts offering 12 month price targets for Flora Growth Corp.
Min Forecast
$6.00+358.02%
Avg Forecast
$6.50+396.18%
Max Forecast
$7.00+434.35%

Should I buy or sell FLGC stock?

Based on 2 analysts offering ratings for Flora Growth Corp.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FLGC stock forecasts and price targets.

FLGC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-04-03

1 of 1

Forecast return on equity

Is FLGC forecast to generate an efficient return?
Company
N/A
Industry
28.62%
Market
24.15%

Forecast return on assets

Is FLGC forecast to generate an efficient return on assets?
Company
N/A
Industry
13.11%

FLGC revenue forecast

What is FLGC's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$77.9M+4.12%
Avg 2 year Forecast
$85.9M+14.82%
FLGC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FLGC revenue growth forecast

How is FLGC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
4.12%
Industry
10.08%
Market
14.09%
FLGC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FLGC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FLGC vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
FLGC$1.31$6.50+396.18%Strong Buy
AYTU$2.94N/AN/A
RDHL$0.47N/AN/A
TLPH$1.08$4.50+316.67%Strong Buy
KALA$6.55$16.50+151.91%Buy
View Top Pharmaceutical Stocks

Flora Growth Stock Forecast FAQ

Is Flora Growth Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: FLGC) stock is to Strong Buy FLGC stock.

Out of 2 analysts, 2 (100%) are recommending FLGC as a Strong Buy, 0 (0%) are recommending FLGC as a Buy, 0 (0%) are recommending FLGC as a Hold, 0 (0%) are recommending FLGC as a Sell, and 0 (0%) are recommending FLGC as a Strong Sell.

If you're new to stock investing, here's how to buy Flora Growth stock.

What is FLGC's revenue growth forecast for 2024-2025?

(NASDAQ: FLGC) Flora Growth's forecast annual revenue growth rate of 4.12% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.09%.

Flora Growth's revenue in 2024 is $74,783,000.On average, 2 Wall Street analysts forecast FLGC's revenue for 2024 to be $997,946,681, with the lowest FLGC revenue forecast at $976,350,820, and the highest FLGC revenue forecast at $1,019,555,359.

In 2025, FLGC is forecast to generate $1,100,491,778 in revenue, with the lowest revenue forecast at $1,094,929,402 and the highest revenue forecast at $1,106,066,971.

What is FLGC's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: FLGC) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.11%.

What is FLGC's Price Target?

According to 2 Wall Street analysts that have issued a 1 year FLGC price target, the average FLGC price target is $6.50, with the highest FLGC stock price forecast at $7.00 and the lowest FLGC stock price forecast at $6.00.

On average, Wall Street analysts predict that Flora Growth's share price could reach $6.50 by May 16, 2025. The average Flora Growth stock price prediction forecasts a potential upside of 396.18% from the current FLGC share price of $1.31.

What is FLGC's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: FLGC) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.